Drug Type Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC) |
Synonyms 111In-labelled imaging agent (Ashvattha), 111In-labelled targetting M2 macrophage (Ashvattha), HD6-DOTA-111In + [1] |
Target- |
Action enhancers |
Mechanism SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Preclinical | United States | - | |
| Neoplasm Metastasis | Preclinical | United States | - |





